Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation.
暂无分享,去创建一个
[1] P. Bulpa,et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease , 2007, European Respiratory Journal.
[2] J. Bates,et al. Tumor Necrosis Factor–α Overexpression in Lung Disease , 2005 .
[3] J. Bates,et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. , 2005, American journal of respiratory and critical care medicine.
[4] A. Ionescu,et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[5] Susan C Kandarian,et al. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. , 2004, The Journal of clinical investigation.
[6] W. Frontera,et al. IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.
[7] E. Wouters,et al. Tumor necrosis factor‐alpha inhibits myogenic differentiation through MyoD protein destabilization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] W. Frontera,et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.
[9] D. Glass,et al. Molecular mechanisms modulating muscle mass. , 2003, Trends in molecular medicine.
[10] D. Freyssenet,et al. Myogenic and nonmyogenic cells differentially express proteinases, Hsc/Hsp70, and BAG-1 during skeletal muscle regeneration. , 2003, American journal of physiology. Endocrinology and metabolism.
[11] E. Wouters,et al. Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis , 2003, In Vitro Cellular & Developmental Biology - Animal.
[12] E. Senba,et al. In Vivo Activation of STAT3 Signaling in Satellite Cells and Myofibers in Regenerating Rat Skeletal Muscles , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] G. Pavlath,et al. A muscle precursor cell-dependent pathway contributes to muscle growth after atrophy. , 2001, American journal of physiology. Cell physiology.
[15] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[16] A. Ionescu,et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[17] T. Hawke,et al. Myogenic satellite cells: physiology to molecular biology. , 2001, Journal of applied physiology.
[18] E. Wouters,et al. Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-b , 2022 .
[19] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[20] M. Fujita,et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[21] E. Wouters,et al. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] C. Y. Wang,et al. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. , 2000, Science.
[23] R. de Waal Malefyt,et al. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. , 2000, International immunology.
[24] H. Saito,et al. The Relationship between Chronic Hypoxemia and Activation of the Tumor Necrosis Factor- α System in Patients with Chronic Obstructive Pulmonary Disease , 2000 .
[25] M. H. Snow,et al. Activity‐induced fiber regeneration in rat soleus muscle , 2000, The Anatomical record.
[26] H. Saito,et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[27] V. Edgerton,et al. Myonuclear domains in muscle adaptation and disease , 1999, Muscle & nerve.
[28] Chris Albanese,et al. NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.
[29] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[30] E. Wouters,et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[31] A. Goldberg,et al. Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Schwartz,et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .
[33] R. Schwartz,et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[35] T. Vary,et al. Sepsis inhibits synthesis of myofibrillar and sarcoplasmic proteins: modulation by interleukin-1 receptor antagonist. , 1996, Shock.
[36] M. Buck,et al. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. , 1996, The EMBO journal.
[37] P. Barnes,et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.
[38] J. Whitsett,et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. , 1995, The Journal of clinical investigation.
[39] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[40] D. Gouma,et al. Tissue distribution and clearance of soluble murine TNF receptors in mice. , 1994, Cytokine.
[41] J. Miller,et al. Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro. , 1992, Developmental biology.
[42] S. Heymsfield,et al. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. , 1990, The American journal of clinical nutrition.
[43] K. Tracey,et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. , 1989, The American journal of physiology.
[44] Torti,et al. Tumor necrosis factor inhibits human myogenesis in vitro , 1988, Molecular and cellular biology.
[45] J. Lough,et al. Modulation of histone H3 variant synthesis during the myoblast-myotube transition of chicken myogenesis. , 1987, Developmental biology.